Stereotactic ablative radiotherapy for ultra-central lung tumors: prioritize target coverage or organs at risk? View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2018-12

AUTHORS

Donna H. Murrell, Joanna M. Laba, Abigail Erickson, Barbara Millman, David A. Palma, Alexander V. Louie

ABSTRACT

BACKGROUND: Lung stereotactic ablative radiotherapy (SABR) is associated with low morbidity, however there is an increased risk of treatment-related toxicity in tumors directly abutting or invading the proximal bronchial tree, termed 'ultra-central' tumors. As there is no consensus regarding the optimal radiotherapy treatment regimen for these tumors, we performed a modeling study to evaluate the trade-offs between predicted toxicity and local control for commonly used high-precision dose-fractionation regimens. METHODS: Ten patients with ultra-central lung tumors were identified from our institutional database. New plans were generated for 3 different hypofractionated schemes: 50 Gy in 5 fractions, 60 Gy in 8 fractions and 60 Gy in 15 fractions. For each regimen, one plan was created that prioritized planning target volume (PTV) coverage, potentially at the expense of organ at risk (OAR) tolerance, and a second that compromised PTV coverage to respect OAR dose constraints. Published radiobiological models were employed to evaluate competing treatment plans based on estimates for local control and the likelihood for toxicity to OAR. RESULTS: The risk of esophageal or pulmonary toxicity was low (< 5%) in all scenarios. When PTV coverage was prioritized, tumor control probabilities were 92.9% for 50 Gy in 5 fractions, 92.4% for 60 Gy in 8 fractions, and 52.0% for 60 Gy in 15 fractions; however the estimated risk of grade ≥ 4 toxicity to the proximal bronchial tree was 68%, 44% and 2% respectively. When dose to OAR was prioritized, the risk of major pulmonary toxicity was reduced to < 1% in all schemes, but this compromise reduced tumor control probability to 60.3% for 50 Gy in 5 fractions, 65.7% for 60 Gy in 8 fractions and 47.8% for 60 Gy in 15 fractions. CONCLUSIONS: The tradeoff between local control and central airway toxicity are considerable in the use of 3 commonly used hypofractionated radiotherapy regimens for ultra-central lung cancer. The results of this planning study predict that the best balance may be achieved with 60 Gy in 8 fractions compromising PTV coverage as required to maintain acceptable doses to OAR. A prospective phase I trial (SUNSET) is planned to further evaluate this challenging clinical scenario. More... »

PAGES

57

References to SciGraph publications

Identifiers

URI

http://scigraph.springernature.com/pub.10.1186/s13014-018-1001-6

DOI

http://dx.doi.org/10.1186/s13014-018-1001-6

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1101899146

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/29606150


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Carcinoma, Non-Small-Cell Lung", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Computer Simulation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Dose Fractionation, Radiation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Lung Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Organs at Risk", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Radiobiology", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Radiosurgery", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Radiotherapy Dosage", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Radiotherapy Planning, Computer-Assisted", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Radiotherapy, Intensity-Modulated", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "London Health Sciences Centre", 
          "id": "https://www.grid.ac/institutes/grid.412745.1", 
          "name": [
            "Department of Physics and Engineering, London Regional Cancer Program, London, ON, Canada"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Murrell", 
        "givenName": "Donna H.", 
        "id": "sg:person.01031162014.66", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01031162014.66"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "London Health Sciences Centre", 
          "id": "https://www.grid.ac/institutes/grid.412745.1", 
          "name": [
            "Department of Radiation Oncology, London Health Sciences Centre, 790 Commissioners Road East, London, ON, Canada"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Laba", 
        "givenName": "Joanna M.", 
        "id": "sg:person.010161520004.24", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010161520004.24"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "London Health Sciences Centre", 
          "id": "https://www.grid.ac/institutes/grid.412745.1", 
          "name": [
            "Department of Physics and Engineering, London Regional Cancer Program, London, ON, Canada"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Erickson", 
        "givenName": "Abigail", 
        "id": "sg:person.01134663724.93", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01134663724.93"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "London Health Sciences Centre", 
          "id": "https://www.grid.ac/institutes/grid.412745.1", 
          "name": [
            "Department of Physics and Engineering, London Regional Cancer Program, London, ON, Canada"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Millman", 
        "givenName": "Barbara", 
        "id": "sg:person.01137256577.45", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01137256577.45"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "London Health Sciences Centre", 
          "id": "https://www.grid.ac/institutes/grid.412745.1", 
          "name": [
            "Department of Radiation Oncology, London Health Sciences Centre, 790 Commissioners Road East, London, ON, Canada"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Palma", 
        "givenName": "David A.", 
        "id": "sg:person.01236460447.16", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01236460447.16"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "London Health Sciences Centre", 
          "id": "https://www.grid.ac/institutes/grid.412745.1", 
          "name": [
            "Department of Radiation Oncology, London Health Sciences Centre, 790 Commissioners Road East, London, ON, Canada"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Louie", 
        "givenName": "Alexander V.", 
        "id": "sg:person.01241271063.72", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01241271063.72"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1097/jto.0000000000000260", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1005422452"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0360-3016(90)90037-k", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010628716"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmc1203770", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1015135905"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0360-3016(91)90172-z", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1019342961"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/s13014-015-0567-5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1026098691", 
          "https://doi.org/10.1186/s13014-015-0567-5"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0360-3016(02)03986-x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1029940849"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0360-3016(02)03986-x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1029940849"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.semradonc.2008.04.001", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1034325725"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/s13014-016-0608-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1037090136", 
          "https://doi.org/10.1186/s13014-016-0608-8"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ijrobp.2015.01.044", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1039403393"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ijrobp.2004.07.691", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1039794255"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.radonc.2005.03.021", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042392919"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/s13014-016-0693-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042497386", 
          "https://doi.org/10.1186/s13014-016-0693-8"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/s13014-016-0693-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042497386", 
          "https://doi.org/10.1186/s13014-016-0693-8"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.jtho.2016.03.008", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042903145"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2013.51.5353", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1043353542"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0360-3016(97)00584-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1044824238"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/s13014-015-0429-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1047026321", 
          "https://doi.org/10.1186/s13014-015-0429-1"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/s13014-015-0429-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1047026321", 
          "https://doi.org/10.1186/s13014-015-0429-1"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.prro.2015.09.012", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1047911856"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/1756-8722-3-39", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1048329514", 
          "https://doi.org/10.1186/1756-8722-3-39"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.lungcan.2015.04.014", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1051878544"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1118/1.596781", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052456160"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.radonc.2005.10.001", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052698687"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0169-5002(99)00019-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052947722"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1088/0031-9155/53/3/014", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1059027459"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1259/bjr.20150036", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064565575"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2018-12", 
    "datePublishedReg": "2018-12-01", 
    "description": "BACKGROUND: Lung stereotactic ablative radiotherapy (SABR) is associated with low morbidity, however there is an increased risk of treatment-related toxicity in tumors directly abutting or invading the proximal bronchial tree, termed 'ultra-central' tumors. As there is no consensus regarding the optimal radiotherapy treatment regimen for these tumors, we performed a modeling study to evaluate the trade-offs between predicted toxicity and local control for commonly used high-precision dose-fractionation regimens.\nMETHODS: Ten patients with ultra-central lung tumors were identified from our institutional database. New plans were generated for 3 different hypofractionated schemes: 50\u00a0Gy in 5 fractions, 60\u00a0Gy in 8 fractions and 60\u00a0Gy in 15 fractions. For each regimen, one plan was created that prioritized planning target volume (PTV) coverage, potentially at the expense of organ at risk (OAR) tolerance, and a second that compromised PTV coverage to respect OAR dose constraints. Published radiobiological models were employed to evaluate competing treatment plans based on estimates for local control and the likelihood for toxicity to OAR.\nRESULTS: The risk of esophageal or pulmonary toxicity was low (<\u20095%) in all scenarios. When PTV coverage was prioritized, tumor control probabilities were 92.9% for 50\u00a0Gy in 5 fractions, 92.4% for 60\u00a0Gy in 8 fractions, and 52.0% for 60\u00a0Gy in 15 fractions; however the estimated risk of grade\u2009\u2265\u20094 toxicity to the proximal bronchial tree was 68%, 44% and 2% respectively. When dose to OAR was prioritized, the risk of major pulmonary toxicity was reduced to <\u20091% in all schemes, but this compromise reduced tumor control probability to 60.3% for 50\u00a0Gy in 5 fractions, 65.7% for 60\u00a0Gy in 8 fractions and 47.8% for 60\u00a0Gy in 15 fractions.\nCONCLUSIONS: The tradeoff between local control and central airway toxicity are considerable in the use of 3 commonly used hypofractionated radiotherapy regimens for ultra-central lung cancer. The results of this planning study predict that the best balance may be achieved with 60\u00a0Gy in 8 fractions compromising PTV coverage as required to maintain acceptable doses to OAR. A prospective phase I trial (SUNSET) is planned to further evaluate this challenging clinical scenario.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1186/s13014-018-1001-6", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1036451", 
        "issn": [
          "1748-717X"
        ], 
        "name": "Radiation Oncology", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "13"
      }
    ], 
    "name": "Stereotactic ablative radiotherapy for ultra-central lung tumors: prioritize target coverage or organs at risk?", 
    "pagination": "57", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "cf69c596ea13d4272dbcb36e0915f7e45b451587a80ae3bc56b32422e5e71af8"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "29606150"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "101265111"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1186/s13014-018-1001-6"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1101899146"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1186/s13014-018-1001-6", 
      "https://app.dimensions.ai/details/publication/pub.1101899146"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T14:03", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000371_0000000371/records_130831_00000005.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://link.springer.com/10.1186%2Fs13014-018-1001-6"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/s13014-018-1001-6'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/s13014-018-1001-6'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/s13014-018-1001-6'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/s13014-018-1001-6'


 

This table displays all metadata directly associated to this object as RDF triples.

225 TRIPLES      21 PREDICATES      64 URIs      32 LITERALS      20 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1186/s13014-018-1001-6 schema:about N39ec1c1614494eafa1e7d9164b025d69
2 N4e7cc287523b4b9790964f0a70f52164
3 N5f54cb5e6e2c43ba9b387b4de0b0e0cb
4 N76c4c6c5e1be4d2cb1960aef0165caf5
5 N98405e2f71cb4d5d8f01753c1130f945
6 Na09206a381ef461983c8c439ebeb0bdd
7 Nb5d32b5d4a754413abb25f62a298f09b
8 Nc574395840bc466fbcb5c0565667d75e
9 Ncae4a47298454668bd8925d213dca098
10 Nccac9fb73a50430b81fb8f4432414cc0
11 Nfbf88bc124e846a5b5533f822a90e359
12 anzsrc-for:11
13 anzsrc-for:1112
14 schema:author N7cacb04eb6b64c90a262d786f78eb95e
15 schema:citation sg:pub.10.1186/1756-8722-3-39
16 sg:pub.10.1186/s13014-015-0429-1
17 sg:pub.10.1186/s13014-015-0567-5
18 sg:pub.10.1186/s13014-016-0608-8
19 sg:pub.10.1186/s13014-016-0693-8
20 https://doi.org/10.1016/0360-3016(90)90037-k
21 https://doi.org/10.1016/0360-3016(91)90172-z
22 https://doi.org/10.1016/j.ijrobp.2004.07.691
23 https://doi.org/10.1016/j.ijrobp.2015.01.044
24 https://doi.org/10.1016/j.jtho.2016.03.008
25 https://doi.org/10.1016/j.lungcan.2015.04.014
26 https://doi.org/10.1016/j.prro.2015.09.012
27 https://doi.org/10.1016/j.radonc.2005.03.021
28 https://doi.org/10.1016/j.radonc.2005.10.001
29 https://doi.org/10.1016/j.semradonc.2008.04.001
30 https://doi.org/10.1016/s0169-5002(99)00019-7
31 https://doi.org/10.1016/s0360-3016(02)03986-x
32 https://doi.org/10.1016/s0360-3016(97)00584-1
33 https://doi.org/10.1056/nejmc1203770
34 https://doi.org/10.1088/0031-9155/53/3/014
35 https://doi.org/10.1097/jto.0000000000000260
36 https://doi.org/10.1118/1.596781
37 https://doi.org/10.1200/jco.2013.51.5353
38 https://doi.org/10.1259/bjr.20150036
39 schema:datePublished 2018-12
40 schema:datePublishedReg 2018-12-01
41 schema:description BACKGROUND: Lung stereotactic ablative radiotherapy (SABR) is associated with low morbidity, however there is an increased risk of treatment-related toxicity in tumors directly abutting or invading the proximal bronchial tree, termed 'ultra-central' tumors. As there is no consensus regarding the optimal radiotherapy treatment regimen for these tumors, we performed a modeling study to evaluate the trade-offs between predicted toxicity and local control for commonly used high-precision dose-fractionation regimens. METHODS: Ten patients with ultra-central lung tumors were identified from our institutional database. New plans were generated for 3 different hypofractionated schemes: 50 Gy in 5 fractions, 60 Gy in 8 fractions and 60 Gy in 15 fractions. For each regimen, one plan was created that prioritized planning target volume (PTV) coverage, potentially at the expense of organ at risk (OAR) tolerance, and a second that compromised PTV coverage to respect OAR dose constraints. Published radiobiological models were employed to evaluate competing treatment plans based on estimates for local control and the likelihood for toxicity to OAR. RESULTS: The risk of esophageal or pulmonary toxicity was low (< 5%) in all scenarios. When PTV coverage was prioritized, tumor control probabilities were 92.9% for 50 Gy in 5 fractions, 92.4% for 60 Gy in 8 fractions, and 52.0% for 60 Gy in 15 fractions; however the estimated risk of grade ≥ 4 toxicity to the proximal bronchial tree was 68%, 44% and 2% respectively. When dose to OAR was prioritized, the risk of major pulmonary toxicity was reduced to < 1% in all schemes, but this compromise reduced tumor control probability to 60.3% for 50 Gy in 5 fractions, 65.7% for 60 Gy in 8 fractions and 47.8% for 60 Gy in 15 fractions. CONCLUSIONS: The tradeoff between local control and central airway toxicity are considerable in the use of 3 commonly used hypofractionated radiotherapy regimens for ultra-central lung cancer. The results of this planning study predict that the best balance may be achieved with 60 Gy in 8 fractions compromising PTV coverage as required to maintain acceptable doses to OAR. A prospective phase I trial (SUNSET) is planned to further evaluate this challenging clinical scenario.
42 schema:genre research_article
43 schema:inLanguage en
44 schema:isAccessibleForFree true
45 schema:isPartOf N24ce3fe2a5aa46cd907f34a7b569a433
46 N796bf203b40e4be4b0a18a906939770e
47 sg:journal.1036451
48 schema:name Stereotactic ablative radiotherapy for ultra-central lung tumors: prioritize target coverage or organs at risk?
49 schema:pagination 57
50 schema:productId Na74cf0a5b87c415581e56430f0329f8e
51 Nd694264603244fd8a240591d01fb0ddb
52 Nda1211f0329f43319f7e84897fc26c53
53 Nee02dfbcdd28446b8c65eecfc34a7ae9
54 Nfd7ed0fb26e240eea582de0f78cc1462
55 schema:sameAs https://app.dimensions.ai/details/publication/pub.1101899146
56 https://doi.org/10.1186/s13014-018-1001-6
57 schema:sdDatePublished 2019-04-11T14:03
58 schema:sdLicense https://scigraph.springernature.com/explorer/license/
59 schema:sdPublisher Nf058d8dbb18d4a11894d61fce88bcf95
60 schema:url https://link.springer.com/10.1186%2Fs13014-018-1001-6
61 sgo:license sg:explorer/license/
62 sgo:sdDataset articles
63 rdf:type schema:ScholarlyArticle
64 N24ce3fe2a5aa46cd907f34a7b569a433 schema:issueNumber 1
65 rdf:type schema:PublicationIssue
66 N304486faf2464f5f9f9f11f9d591e893 rdf:first sg:person.010161520004.24
67 rdf:rest N49414e20fe804013a5749370cddbb4f3
68 N39ec1c1614494eafa1e7d9164b025d69 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
69 schema:name Radiotherapy Planning, Computer-Assisted
70 rdf:type schema:DefinedTerm
71 N49414e20fe804013a5749370cddbb4f3 rdf:first sg:person.01134663724.93
72 rdf:rest Ne93414ef9144472898970da913d20623
73 N4e7cc287523b4b9790964f0a70f52164 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
74 schema:name Radiotherapy Dosage
75 rdf:type schema:DefinedTerm
76 N4ee56b37eda14cefb70c11a675139ed0 rdf:first sg:person.01236460447.16
77 rdf:rest Na1fcbdfb5b0c40ef86c0b66f74866274
78 N5f54cb5e6e2c43ba9b387b4de0b0e0cb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
79 schema:name Lung Neoplasms
80 rdf:type schema:DefinedTerm
81 N76c4c6c5e1be4d2cb1960aef0165caf5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
82 schema:name Radiosurgery
83 rdf:type schema:DefinedTerm
84 N796bf203b40e4be4b0a18a906939770e schema:volumeNumber 13
85 rdf:type schema:PublicationVolume
86 N7cacb04eb6b64c90a262d786f78eb95e rdf:first sg:person.01031162014.66
87 rdf:rest N304486faf2464f5f9f9f11f9d591e893
88 N98405e2f71cb4d5d8f01753c1130f945 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
89 schema:name Dose Fractionation, Radiation
90 rdf:type schema:DefinedTerm
91 Na09206a381ef461983c8c439ebeb0bdd schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
92 schema:name Organs at Risk
93 rdf:type schema:DefinedTerm
94 Na1fcbdfb5b0c40ef86c0b66f74866274 rdf:first sg:person.01241271063.72
95 rdf:rest rdf:nil
96 Na74cf0a5b87c415581e56430f0329f8e schema:name doi
97 schema:value 10.1186/s13014-018-1001-6
98 rdf:type schema:PropertyValue
99 Nb5d32b5d4a754413abb25f62a298f09b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
100 schema:name Radiotherapy, Intensity-Modulated
101 rdf:type schema:DefinedTerm
102 Nc574395840bc466fbcb5c0565667d75e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
103 schema:name Computer Simulation
104 rdf:type schema:DefinedTerm
105 Ncae4a47298454668bd8925d213dca098 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
106 schema:name Radiobiology
107 rdf:type schema:DefinedTerm
108 Nccac9fb73a50430b81fb8f4432414cc0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
109 schema:name Humans
110 rdf:type schema:DefinedTerm
111 Nd694264603244fd8a240591d01fb0ddb schema:name dimensions_id
112 schema:value pub.1101899146
113 rdf:type schema:PropertyValue
114 Nda1211f0329f43319f7e84897fc26c53 schema:name nlm_unique_id
115 schema:value 101265111
116 rdf:type schema:PropertyValue
117 Ne93414ef9144472898970da913d20623 rdf:first sg:person.01137256577.45
118 rdf:rest N4ee56b37eda14cefb70c11a675139ed0
119 Nee02dfbcdd28446b8c65eecfc34a7ae9 schema:name pubmed_id
120 schema:value 29606150
121 rdf:type schema:PropertyValue
122 Nf058d8dbb18d4a11894d61fce88bcf95 schema:name Springer Nature - SN SciGraph project
123 rdf:type schema:Organization
124 Nfbf88bc124e846a5b5533f822a90e359 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
125 schema:name Carcinoma, Non-Small-Cell Lung
126 rdf:type schema:DefinedTerm
127 Nfd7ed0fb26e240eea582de0f78cc1462 schema:name readcube_id
128 schema:value cf69c596ea13d4272dbcb36e0915f7e45b451587a80ae3bc56b32422e5e71af8
129 rdf:type schema:PropertyValue
130 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
131 schema:name Medical and Health Sciences
132 rdf:type schema:DefinedTerm
133 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
134 schema:name Oncology and Carcinogenesis
135 rdf:type schema:DefinedTerm
136 sg:journal.1036451 schema:issn 1748-717X
137 schema:name Radiation Oncology
138 rdf:type schema:Periodical
139 sg:person.010161520004.24 schema:affiliation https://www.grid.ac/institutes/grid.412745.1
140 schema:familyName Laba
141 schema:givenName Joanna M.
142 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010161520004.24
143 rdf:type schema:Person
144 sg:person.01031162014.66 schema:affiliation https://www.grid.ac/institutes/grid.412745.1
145 schema:familyName Murrell
146 schema:givenName Donna H.
147 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01031162014.66
148 rdf:type schema:Person
149 sg:person.01134663724.93 schema:affiliation https://www.grid.ac/institutes/grid.412745.1
150 schema:familyName Erickson
151 schema:givenName Abigail
152 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01134663724.93
153 rdf:type schema:Person
154 sg:person.01137256577.45 schema:affiliation https://www.grid.ac/institutes/grid.412745.1
155 schema:familyName Millman
156 schema:givenName Barbara
157 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01137256577.45
158 rdf:type schema:Person
159 sg:person.01236460447.16 schema:affiliation https://www.grid.ac/institutes/grid.412745.1
160 schema:familyName Palma
161 schema:givenName David A.
162 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01236460447.16
163 rdf:type schema:Person
164 sg:person.01241271063.72 schema:affiliation https://www.grid.ac/institutes/grid.412745.1
165 schema:familyName Louie
166 schema:givenName Alexander V.
167 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01241271063.72
168 rdf:type schema:Person
169 sg:pub.10.1186/1756-8722-3-39 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048329514
170 https://doi.org/10.1186/1756-8722-3-39
171 rdf:type schema:CreativeWork
172 sg:pub.10.1186/s13014-015-0429-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1047026321
173 https://doi.org/10.1186/s13014-015-0429-1
174 rdf:type schema:CreativeWork
175 sg:pub.10.1186/s13014-015-0567-5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1026098691
176 https://doi.org/10.1186/s13014-015-0567-5
177 rdf:type schema:CreativeWork
178 sg:pub.10.1186/s13014-016-0608-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1037090136
179 https://doi.org/10.1186/s13014-016-0608-8
180 rdf:type schema:CreativeWork
181 sg:pub.10.1186/s13014-016-0693-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042497386
182 https://doi.org/10.1186/s13014-016-0693-8
183 rdf:type schema:CreativeWork
184 https://doi.org/10.1016/0360-3016(90)90037-k schema:sameAs https://app.dimensions.ai/details/publication/pub.1010628716
185 rdf:type schema:CreativeWork
186 https://doi.org/10.1016/0360-3016(91)90172-z schema:sameAs https://app.dimensions.ai/details/publication/pub.1019342961
187 rdf:type schema:CreativeWork
188 https://doi.org/10.1016/j.ijrobp.2004.07.691 schema:sameAs https://app.dimensions.ai/details/publication/pub.1039794255
189 rdf:type schema:CreativeWork
190 https://doi.org/10.1016/j.ijrobp.2015.01.044 schema:sameAs https://app.dimensions.ai/details/publication/pub.1039403393
191 rdf:type schema:CreativeWork
192 https://doi.org/10.1016/j.jtho.2016.03.008 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042903145
193 rdf:type schema:CreativeWork
194 https://doi.org/10.1016/j.lungcan.2015.04.014 schema:sameAs https://app.dimensions.ai/details/publication/pub.1051878544
195 rdf:type schema:CreativeWork
196 https://doi.org/10.1016/j.prro.2015.09.012 schema:sameAs https://app.dimensions.ai/details/publication/pub.1047911856
197 rdf:type schema:CreativeWork
198 https://doi.org/10.1016/j.radonc.2005.03.021 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042392919
199 rdf:type schema:CreativeWork
200 https://doi.org/10.1016/j.radonc.2005.10.001 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052698687
201 rdf:type schema:CreativeWork
202 https://doi.org/10.1016/j.semradonc.2008.04.001 schema:sameAs https://app.dimensions.ai/details/publication/pub.1034325725
203 rdf:type schema:CreativeWork
204 https://doi.org/10.1016/s0169-5002(99)00019-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052947722
205 rdf:type schema:CreativeWork
206 https://doi.org/10.1016/s0360-3016(02)03986-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1029940849
207 rdf:type schema:CreativeWork
208 https://doi.org/10.1016/s0360-3016(97)00584-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1044824238
209 rdf:type schema:CreativeWork
210 https://doi.org/10.1056/nejmc1203770 schema:sameAs https://app.dimensions.ai/details/publication/pub.1015135905
211 rdf:type schema:CreativeWork
212 https://doi.org/10.1088/0031-9155/53/3/014 schema:sameAs https://app.dimensions.ai/details/publication/pub.1059027459
213 rdf:type schema:CreativeWork
214 https://doi.org/10.1097/jto.0000000000000260 schema:sameAs https://app.dimensions.ai/details/publication/pub.1005422452
215 rdf:type schema:CreativeWork
216 https://doi.org/10.1118/1.596781 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052456160
217 rdf:type schema:CreativeWork
218 https://doi.org/10.1200/jco.2013.51.5353 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043353542
219 rdf:type schema:CreativeWork
220 https://doi.org/10.1259/bjr.20150036 schema:sameAs https://app.dimensions.ai/details/publication/pub.1064565575
221 rdf:type schema:CreativeWork
222 https://www.grid.ac/institutes/grid.412745.1 schema:alternateName London Health Sciences Centre
223 schema:name Department of Physics and Engineering, London Regional Cancer Program, London, ON, Canada
224 Department of Radiation Oncology, London Health Sciences Centre, 790 Commissioners Road East, London, ON, Canada
225 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...